US › Healthcare

Odyssey Therapeutics, Inc. Common Stock (ODTX)

US · Healthcare · Biotechnology

$19.96+10.09%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-38.3M

EPS

$-6.75

EPS estimate

$-1.28

EPS came in at -6.75 against a street estimate of -1.28 — a miss of 427.0%.

Key statistics

Market cap

$909.2M

Forward P/E

0.0

P/B

0.00

Book value

$-211.05

EPS (TTM)

$-3.15

52-week high

$20.30

52-week low

$15.10

50-day MA

$17.55

200-day MA

$17.53

Analyst view

with an average price target of $32.00.

Shareholding

Insiders

6.08%

Institutions

49.94%

Largest institutional holders

Fund	Stake
Sanofi	4.15%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Odyssey Therapeutics, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.